Mirae Asset Global Investments
LXEO icon

Mirae Asset Global Investments’s Lexeo Therapeutics LXEO Stock Holding History

Mirae Asset Global Investments’s Portfolio LXEO Stock Details LXEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.3K Sell
3,512
-295
-8% -$1.6K ﹤0.01% 1513
2026
Q1 		$21.9K Buy
3,807
+260
+7% +$1.84K ﹤0.01% 1420
2025
Q4 		$35.2K Buy
3,547
+1,459
+70% +$13.3K ﹤0.01% 1467
2025
Q3 		$13.9K Buy
2,088
+806
+63% +$3.9K ﹤0.01% 1535
2025
Q2 		$5.15K Buy
1,282
+303
+31% +$996 ﹤0.01% 1538
2025
Q1 		$4.01K Sell
979
-123
-11% -$545 ﹤0.01% 1522
2024
Q4 		$7.47K Buy
+1,102
New +$8.68K ﹤0.01% 1534

Other funds holding LXEO

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RA Capital Management
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Frazier Life Sciences Management
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vestal Point Capital
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Paradigm Biocapital Advisors
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Jupiter Topco
Jupiter Topco New York $245B AUM
OrbiMed
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Mirae Asset Global Investments's LXEO Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Lexeo Therapeutics (LXEO) stake by 7.7% in Q2 2026, selling an estimated $1.6K and leaving 3,512 shares worth $16.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1513.

Mirae Asset Global Investments first reported a position in LXEO in Q4 2024 and has held it in 7 quarters since. The position peaked at $35.2K in Q4 2025. 141 funds tracked by Wall St. Rank hold LXEO as of Q2 2026.

  • Mirae Asset Global Investments held 3,512 shares of Lexeo Therapeutics worth $16.3K as of Q2 2026.
  • Mirae Asset Global Investments sold 295 Lexeo Therapeutics shares in Q2 2026, an estimated $1.6K.
  • Lexeo Therapeutics made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1513 holding.
  • Mirae Asset Global Investments first reported a position in Lexeo Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • Mirae Asset Global Investments's Lexeo Therapeutics position peaked at $35.2K in Q4 2025.
  • 141 funds tracked by Wall St. Rank held Lexeo Therapeutics as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.